Primary tabs
The list of publications is indicative and may not include all publications.
Clinical impact of dipping and nocturnal blood pressure patterns in newly diagnosed, never-treated patients with essential hypertension..
J Am Soc Hypertens. 12(12), 850-857.
(2018).
Association of non-invasive hemodynamics with arterial stiffness in rheumatoid arthritis..
Scand Cardiovasc J. 52(4), 171-176.
(2018).
The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension..
Ann Intern Med. 168(10), 755.
(2018).
Association of Urinary Sodium Excretion with Vascular Damage: A Local Kidney Effect, Rather Than a Marker of Generalized Vascular Impairment..
Int J Hypertens. 2018, 7620563.
(2018).
Clinical Value of Measuring the Renin/Aldosterone Levels: Optimising the Management of Uncontrolled/Resistant Hypertension..
Curr Vasc Pharmacol. 16(1), 10-14.
(2017).
Impaired Muscle Oxygenation and Elevated Exercise Blood Pressure in Hypertensive Patients: Links With Vascular Stiffness..
Hypertension. 70(2), 444-451.
(2017).
Beneficial effects of nonpharmacological interventions in the management of essential hypertension..
JRSM Cardiovasc Dis. 6, 2048004016683891.
(2017).
Subendocardial viability ratio in patients with rheumatoid arthritis: comparison with healthy controls and identification of prognostic factors..
Clin Rheumatol. 36(6), 1229-1236.
(2017).
Smoking before isometric exercise amplifies myocardial stress and dysregulates baroreceptor sensitivity and cerebral oxygenation..
J Am Soc Hypertens. 11(6), 376-384.
(2017).
Depression, anxiety, and quality of life in a large cohort of patients with rheumatic diseases: common, yet undertreated..
Clin Rheumatol. 35(3), 733-9.
(2016).
Erratum to: Depression, anxiety, and quality of life in a large cohort of patients with rheumatic diseases: common, yet undertreated..
Clin Rheumatol. 35(5), 1411.
(2016).
PATHWAY-2: spironolactone for resistant hypertension..
Lancet. 387(10026), 1372.
(2016).
Predictors of impaired quality of life in patients with rheumatic diseases..
Clin Rheumatol. 35(7), 1705-11.
(2016).
Impaired metabolic profile is a predictor of capillary rarefaction in a population of hypertensive and normotensive individuals..
J Am Soc Hypertens. 10(8), 640-6.
(2016).
Visit-to-visit blood pressure variability: more to come..
J Clin Hypertens (Greenwich). 17(2), 116-7.
(2015).
Antiplatelet treatment in essential hypertension: where do we stand?.
Curr Hypertens Rep. 17(4), 536.
(2015).
Hemodynamic and Arterial Stiffness Parameters in Ambulatory Blood Pressure Phenotypes and the Clinical Scenario of Polypharmacy and Comorbidities..
J Clin Hypertens (Greenwich). 17(8), 655.
(2015).
Response to "Mutual micro- and macrovascular impairment in hypertension: shaping clay into a pot"..
Am J Hypertens. 28(5), 695-6.
(2015).
Capillary rarefaction as an index for the microvascular assessment of hypertensive patients..
Curr Hypertens Rep. 17(5), 33.
(2015).
Platelets interplay between pneumonia and cardiovascular events: establishing a link?.
J Am Coll Cardiol. 65(14), 1487-8.
(2015).